NO996580L - 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat - Google Patents

5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat

Info

Publication number
NO996580L
NO996580L NO996580A NO996580A NO996580L NO 996580 L NO996580 L NO 996580L NO 996580 A NO996580 A NO 996580A NO 996580 A NO996580 A NO 996580A NO 996580 L NO996580 L NO 996580L
Authority
NO
Norway
Prior art keywords
tetrazol
ethyl
methyl
tetrahydropyridine
maleate
Prior art date
Application number
NO996580A
Other languages
English (en)
Other versions
NO996580D0 (no
Inventor
Michael Bech Sommer
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO996580D0 publication Critical patent/NO996580D0/no
Publication of NO996580L publication Critical patent/NO996580L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører et maleatsyre- addisjonssalt av 5-(2-etyl-2tf-tetrazol-5-yl)-1-metyl- 1,2,3,6-tetrahydropyridin, farmasøytiske sammensetninger inneholdende syreaddisjonssaltet og anvendelsen derav for behandlingen av forstyrrelser forårsaket av en svikt i cC.V- eller muskarinsystemet.
NO996580A 1997-07-01 1999-12-30 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat NO996580L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (2)

Publication Number Publication Date
NO996580D0 NO996580D0 (no) 1999-12-30
NO996580L true NO996580L (no) 1999-12-30

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996580A NO996580L (no) 1997-07-01 1999-12-30 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat

Country Status (25)

Country Link
EP (1) EP0994869A1 (no)
JP (1) JP2002507215A (no)
KR (1) KR20010014297A (no)
CN (1) CN1261361A (no)
AR (1) AR013096A1 (no)
AU (1) AU735751B2 (no)
BG (1) BG103933A (no)
BR (1) BR9810331A (no)
CA (1) CA2293324A1 (no)
CO (1) CO4940483A1 (no)
EA (1) EA200000081A1 (no)
HU (1) HUP0002876A2 (no)
IL (1) IL133093A0 (no)
IS (1) IS5278A (no)
JO (1) JO2031B1 (no)
MA (1) MA25138A1 (no)
NO (1) NO996580L (no)
PE (1) PE116099A1 (no)
PL (1) PL337184A1 (no)
SK (1) SK187399A3 (no)
TN (1) TNSN98120A1 (no)
TR (1) TR199903283T2 (no)
UY (2) UY25069A1 (no)
WO (1) WO1999001448A1 (no)
ZA (1) ZA985498B (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
TR199800801T2 (xx) * 1995-11-06 1998-08-21 H. Lund-Beck A/S Travmatik beyin yaralanmalar�n�n tedavisi.

Also Published As

Publication number Publication date
PE116099A1 (es) 1999-11-23
JP2002507215A (ja) 2002-03-05
CO4940483A1 (es) 2000-07-24
BG103933A (en) 2000-07-31
CA2293324A1 (en) 1999-01-14
IS5278A (is) 1999-11-30
AR013096A1 (es) 2000-12-13
SK187399A3 (en) 2000-06-12
NO996580D0 (no) 1999-12-30
HUP0002876A2 (hu) 2001-06-28
CN1261361A (zh) 2000-07-26
TR199903283T2 (xx) 2000-06-21
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
JO2031B1 (en) 1999-05-15
BR9810331A (pt) 2000-09-05
MA25138A1 (fr) 2001-04-02
PL337184A1 (en) 2000-08-14
EP0994869A1 (en) 2000-04-26
UY25069A1 (es) 1998-12-21
WO1999001448A1 (en) 1999-01-14
UY25177A1 (es) 2000-12-29
EA200000081A1 (ru) 2000-08-28
ZA985498B (en) 1999-01-20
IL133093A0 (en) 2001-03-19
KR20010014297A (ko) 2001-02-26
TNSN98120A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
JO3404B1 (ar) تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
BG103297A (en) Aralkyl and aralkyliden heterocyclic lactams and imides
DE69307340D1 (de) Chinuclidin derivat als substanz p antagonist
HK1008819A1 (en) Piperidine derivatives as neurokinin antagonists
NO985977L (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
TR200101962T2 (tr) Sindirim sistemi bozukluklarını tedavi etmek için 4-(aminometil)-piperidin benzamidler
DE69941255D1 (de) Verbindungen mit wachstumshormon freisetzenden eigenschaften
AU4310097A (en) Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
PT615751E (pt) Utilizacao de antagonistas de taquinina no tratamento da emese
TNSN96174A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant.
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
FI943499A0 (fi) Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja
DE69925270D1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
NO975681L (no) Benzisoxazol- og indazol-derivater som antipsykotiske midler
BR9811821A (pt) 2-acilaminopropanaminas como antagonistas de receptores de taquicinina
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
BG103306A (en) Liquid allendronate compositions
WO1996031208A3 (de) Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten
DE69514100D1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
NO996580L (no) 5-(2-etyl-2H-tetrazol-5-yl)-1-metyl-1,2,3,6- tetrahydropyridinmaleat
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
CA2217463A1 (fr) Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application